Verition Fund Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Verition Fund Management's ELV Position: Q2 2026 in Review
Verition Fund Management increased its Elevance Health (ELV) stake by 28% in Q2 2026, buying an estimated $1.31M and bringing the position to 16,138 shares worth $6.24M. The position accounts for 0.03% of the portfolio, ranked #562.
Verition Fund Management first reported a position in ELV in Q3 2013 and has held it in 47 quarters since. The position peaked at $73.7M in Q4 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Verition Fund Management held 16,138 shares of Elevance Health worth $6.24M as of Q2 2026.
- Verition Fund Management bought 3,531 Elevance Health shares in Q2 2026, an estimated $1.31M.
- Elevance Health made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #562 holding.
- Verition Fund Management first reported a position in Elevance Health in Q3 2013 and has held it in 47 quarters since.
- Verition Fund Management's Elevance Health position peaked at $73.7M in Q4 2023.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.